Summary
We studied the effects of oral carvedilol (20 mg/day) on cerebral blood flow (CBF) and CBF autoregulation in ten previous stroke patients with hypertension. Measurement of CBF was done by the argon inhalation method. CBF autoregulation was also studied by the (A-V)O2 method after stepwise reduction in systemic blood pressure. After 1 week of carvedilol administration, the mean arterial blood pressure showed an 18% decrease, with no significant changes in CBF, CBF autoregulation, or other cerebral circulation parameters. From these findings, it can be said that carvedilol is a potent anti-hypertensive agent that does not affect cerebral circulation parameters.
Similar content being viewed by others
References
Strandgaard S, Olesen J, Skinhoj E, Lassen NA (1973) Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1: 507–510
Pevsner PH, Bhushan C, Walker AE (1971) Cerebral blood flow and oxygen consumption. An on-line technique. Johns Hopkins Med J 128: 134–140
Kety SS, Schmidt CF (1945) The determination of cerebral blood flow in man by use of nitrous oxide in low concentrations. Am J Physiol 143: 53–66
Olesen J, Paulson OB, Lassen NA (1971) Regional cerebral blood flow in man determined by the initial slope of the clearance of intraarterially injected133Xe. Stroke 2: 519–540
Hares P, James IM, Griffith D (1977) The effect of acebutolol on the cerebral circulation of man. Br J Clin Pharmacol 4: 373–375
Griffith DN, James IM, Newbury PA, Wollard ML (1979) The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br J Clin Pharmacol 7: 491–494
Barry DI, Paulson OB, Jarden JO, Juhler M, Graham DI, Strandgaard S (1984) Effects of captopril on cerebral blood flow in normotensive and hypertensive rats. Am J Med 76 (5b): 79–85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuriyama, Y., Nakamura, M., Kyougoku, I. et al. Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension. Eur J Clin Pharmacol 38 (Suppl 2), S120–S121 (1990). https://doi.org/10.1007/BF01409479
Issue Date:
DOI: https://doi.org/10.1007/BF01409479